LIGAND PHARMACEUTICALS INC (LGND)

Data as of Oct 6, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch LGND

See up to 3 months of LGND. The 7-day demo opens the 1M and 3M ranges and puts LGND on your watchlist.

Latest LGND insider trades

Andrew Reardon - Officer
Open-market sale$252K
Oct 2, 2026
Andrew Reardon - Officer
Open-market sale

About LIGAND PHARMACEUTICALS INC (LGND)

LIGAND PHARMACEUTICALS INC files with the SEC under CIK 0000886163 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for LGND on EDGAR

LGND Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	24	54,979	$16.07M
Option exercise	16	86,238
Tax withholding / forfeiture	1	115

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

LGND insider transactions (Form 4)

116

61 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 2 of 3.

Date	Insider	Transaction	Security	Shares	Price	Value
Mar 23, 2026	Stephen L. Sabba - Director	Open-market sale	Common Stock	1,000	$207.87^{footnote F2}	$208K
Footnote F2 (price): The price, as represented in Column 4, represents an average price per share of the following transactions on 23 March 2026: 100 shares at $208.055000, 17 shares at $207.980000, and 883 shares at $207.850000.
Mar 11, 2026	Octavio Espinoza - Officer	Option exercise	Employee Stock Option (right to buy)	2,405^{footnote F1}	$0.00	-
Mar 11, 2026	Octavio Espinoza - Officer	Option exercise	Common Stock	2,405^{footnote F1}	$92.65	$223K
Mar 11, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	3,057^{footnote F1}	$225.00	$688K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	1,142^{footnote F1}	$208.87^{footnote F10}	$239K
Mar 4, 2026	Andrew Reardon - Officer	Option exercise	Employee Stock Option (right to buy)	5,000^{footnote F1}	$0.00	-
Mar 4, 2026	Andrew Reardon - Officer	Option exercise	Common Stock	5,000^{footnote F1}	$52.27	$261K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	100^{footnote F1}	$197.70^{footnote F2}	$20K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	100^{footnote F1}	$199.01	$20K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	207^{footnote F1}	$199.96^{footnote F3}	$41K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	93^{footnote F1}	$200.62^{footnote F4}	$19K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	300^{footnote F1}	$201.70	$61K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	200^{footnote F1}	$204.17^{footnote F5}	$41K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	460^{footnote F1}	$205.18^{footnote F6}	$94K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	340^{footnote F1}	$206.37^{footnote F7}	$70K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	612^{footnote F1}	$207.01^{footnote F8}	$127K
Mar 4, 2026	Andrew Reardon - Officer	Open-market sale	Common Stock	1,446^{footnote F1}	$208.12^{footnote F9}	$301K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.5800 to $198.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.8800 to $200.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.5800 to $200.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $203.8600 to $204.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.8400 to $205.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $205.6000 to $206.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $206.6800 to $207.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F9 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.6700 to $208.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F10 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $208.6000 to $208.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	698^{footnote F1}	$201.09^{footnote F4}	$140K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	950^{footnote F1}	$201.73^{footnote F5}	$192K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	697^{footnote F1}	$202.79^{footnote F6}	$141K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	668^{footnote F1}	$203.63^{footnote F7}	$136K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	743^{footnote F1}	$204.74^{footnote F8}	$152K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	1,457^{footnote F1}	$205.79^{footnote F9}	$300K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	1,588^{footnote F1}	$206.89^{footnote F10}	$329K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	2,457^{footnote F1}	$207.91^{footnote F11}	$511K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	3,413^{footnote F1}	$208.80^{footnote F12}	$713K
Mar 4, 2026	Octavio Espinoza - Officer	Option exercise	Employee Stock Option (right to buy)	1,607^{footnote F1}	$0.00	-
Mar 4, 2026	Octavio Espinoza - Officer	Option exercise	Employee Stock Option (right to buy)	466^{footnote F1}	$0.00	-
Mar 4, 2026	Octavio Espinoza - Officer	Option exercise	Common Stock	1,607^{footnote F1}	$58.49	$94K
Mar 4, 2026	Octavio Espinoza - Officer	Option exercise	Common Stock	466^{footnote F1}	$80.72	$38K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	699^{footnote F1}	$198.71^{footnote F2}	$139K
Mar 4, 2026	Octavio Espinoza - Officer	Open-market sale	Common Stock	53^{footnote F1}	$200.08^{footnote F3}	$11K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.3700 to $199.2500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4400 to $200.0900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.5000 to $201.3400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.4600 to $202.3300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.4000 to $203.0500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $203.4100 to $203.8600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.4600 to $205.3600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F9 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $205.3700 to $206.3600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F10 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $206.4700 to $207.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F11 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.4100 to $208.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F12 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $208.3900 to $208.9500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Mar 3, 2026	Stephen L. Sabba - Director	Option exercise	Non- Qualified Stock Option (right to buy)	2,034	$0.00	-
Mar 3, 2026	Stephen L. Sabba - Director	Option exercise	Common Stock	2,034	$69.51	$141K
Mar 3, 2026	Stephen L. Sabba - Director	Open-market sale	Common Stock	2,034	$201.50	$410K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	41^{footnote F1}	$200.40^{footnote F4}	$8K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	83^{footnote F1}	$201.65^{footnote F5}	$17K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	50^{footnote F1}	$202.54^{footnote F6}	$10K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	42^{footnote F1}	$203.57	$9K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	47^{footnote F1}	$197.14^{footnote F2}	$9K
Mar 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	204^{footnote F1}	$199.69^{footnote F3}	$41K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.0650 to $197.2000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4100 to $200.0550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.1050 to $200.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.2150 to $202.0500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.1500 to $202.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Feb 14, 2026	Andrew Reardon - Officer	Grant or award	Common Stock	6,928	$0.00^{footnote F1}	-
Feb 14, 2026	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	3,211^{footnote F2}	$183.83	$590K
Feb 14, 2026	Andrew Reardon - Officer	Grant or award	Common Stock	8,810	$0.00^{footnote F1}	-
Feb 14, 2026	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	4,083^{footnote F2}	$183.83	$751K
Feb 15, 2026	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	593^{footnote F3}	$183.83	$109K
Feb 15, 2026	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	801^{footnote F3}	$183.83	$147K
Feb 15, 2026	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	992^{footnote F3}	$183.83	$182K
Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs"). Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs. Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Feb 14, 2026	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	4,483^{footnote F2}	$183.83	$824K
Feb 15, 2026	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	1,026^{footnote F3}	$183.83	$189K
Feb 15, 2026	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	1,223^{footnote F3}	$183.83	$225K
Feb 15, 2026	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	1,270^{footnote F3}	$183.83	$233K
Feb 14, 2026	Octavio Espinoza - Officer	Grant or award	Common Stock	7,390	$0.00^{footnote F1}	-
Feb 14, 2026	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	3,761^{footnote F2}	$183.83	$691K
Feb 14, 2026	Octavio Espinoza - Officer	Grant or award	Common Stock	8,810	$0.00^{footnote F1}	-
Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs"). Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs. Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Feb 14, 2026	Todd C. Davis - Officer	Grant or award	Common Stock	20,782	$0.00^{footnote F1}	-
Feb 14, 2026	Todd C. Davis - Officer	Tax withholding / forfeiture	Common Stock	8,178^{footnote F2}	$183.83	$1.50M
Feb 14, 2026	Todd C. Davis - Officer	Grant or award	Common Stock	39,644	$0.00^{footnote F1}	-
Feb 14, 2026	Todd C. Davis - Officer	Tax withholding / forfeiture	Common Stock	15,600^{footnote F2}	$183.83	$2.87M
Feb 15, 2026	Todd C. Davis - Officer	Tax withholding / forfeiture	Common Stock	2,039^{footnote F3}	$183.83	$375K
Feb 15, 2026	Todd C. Davis - Officer	Tax withholding / forfeiture	Common Stock	4,255^{footnote F3}	$183.83	$782K
Feb 15, 2026	Todd C. Davis - Officer	Tax withholding / forfeiture	Common Stock	2,805^{footnote F3}	$183.83	$516K
Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs"). Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs. Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Feb 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	39^{footnote F1}	$191.00	$7K
Feb 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	1^{footnote F1}	$192.18	$192
Feb 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	23^{footnote F1}	$195.61	$4K
Feb 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	381^{footnote F1}	$196.36^{footnote F2}	$75K
Feb 2, 2026	John W. Kozarich - Director	Open-market sale	Common Stock	23^{footnote F1}	$197.20	$5K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.0100 to $196.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Dec 12, 2025	Octavio Espinoza - Officer	Open-market sale	Common Stock	1,804	$188.31	$340K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	92^{footnote F1}	$193.86^{footnote F2}	$18K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	179^{footnote F1}	$194.76^{footnote F3}	$35K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	47^{footnote F1}	$195.80^{footnote F4}	$9K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	4^{footnote F1}	$196.35^{footnote F5}	$785
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	92^{footnote F1}	$197.72^{footnote F6}	$18K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	23^{footnote F1}	$199.22^{footnote F7}	$5K
Dec 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	30^{footnote F1}	$200.02^{footnote F8}	$6K
Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $193.2800 to $194.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $194.2800 to $195.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $195.2800 to $196.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.2800 to $197.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.2800 to $198.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.2800 to $199.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.2800 to $200.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Nov 7, 2025	Nancy Ryan Gray - Director	Option exercise	Non-Qualified Stock Option (right to buy)	3,015	$0.00	-
Nov 7, 2025	Nancy Ryan Gray - Director	Option exercise	Common Stock	3,556	$66.19	$235K
Nov 7, 2025	Nancy Ryan Gray - Director	Open-market sale	Common Stock	3,556	$205.45	$731K
Nov 7, 2025	Nancy Ryan Gray - Director	Option exercise	Common Stock	3,015	$73.57	$222K
Nov 7, 2025	Nancy Ryan Gray - Director	Open-market sale	Common Stock	3,015	$205.45	$619K
Nov 7, 2025	Nancy Ryan Gray - Director	Option exercise	Non-Qualified Stock Option (right to buy)	3,556	$0.00	-
Nov 7, 2025	John L. Lamattina - Director	Option exercise	Non-Qualified Stock Option (right to buy)	2,145	$0.00	-
Nov 7, 2025	John L. Lamattina - Director	Option exercise	Non-Qualified Stock Option (right to buy)	2,034	$0.00	-
Nov 7, 2025	John L. Lamattina - Director	Option exercise	Common Stock	2,145	$66.13	$142K
Nov 7, 2025	John L. Lamattina - Director	Open-market sale	Common Stock	2,145	$205.45	$441K
Nov 7, 2025	John L. Lamattina - Director	Option exercise	Common Stock	2,034	$69.51	$141K
Nov 7, 2025	John L. Lamattina - Director	Open-market sale	Common Stock	2,034	$205.45	$418K
Nov 3, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	49^{footnote F1}	$190.26^{footnote F3}	$9K
Nov 3, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	207^{footnote F1}	$191.25^{footnote F4}	$40K
Nov 3, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	127^{footnote F1}	$192.38^{footnote F5}	$24K
Nov 3, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	84^{footnote F1}	$189.00^{footnote F2}	$16K
Footnote F1 (shares): The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.7150 to $189.5250. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $190.9400 to $191.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $192.1200 to $192.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Oct 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	24^{footnote F1}	$177.60^{footnote F2}	$4K
Oct 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	196^{footnote F1}	$178.41^{footnote F3}	$35K
Oct 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	155^{footnote F1}	$180.01^{footnote F4}	$28K
Oct 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	92^{footnote F1}	$181.18^{footnote F5}	$17K
Footnote F1 (shares): The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $176.6800 to $177.6450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $177.8750 to $178.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $179.4800 to $180.3100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $180.9350 to $181.4000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Sep 23, 2025	Jason Aryeh - Director	Open-market sale	Common Stock	4,418	$170.41	$753K
Sep 23, 2025	Jason Aryeh - Director	Open-market sale	Common Stock	4,628	$170.96	$791K
Sep 23, 2025	Jason Aryeh - Director	Open-market sale	Common Stock	954	$171.92	$164K
Sep 22, 2025	Martine Zimmermann - Director	Tax withholding / forfeiture	Common Stock	115	$170.77	$20K
Sep 2, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	267	$161.51	$43K
Sep 2, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	115	$162.52	$19K
Sep 2, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	85	$164.25	$14K
Aug 10, 2025	Andrew Reardon - Officer	Tax withholding / forfeiture	Common Stock	1,325	$150.06	$199K
Aug 1, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	467	$131.88	$62K
Jul 10, 2025	John W. Kozarich - Director	Open-market sale	Common Stock	934	$125.00	$117K
Jun 30, 2025	Andrew Reardon - Officer	Other	Common Stock	233	$91.08	$21K
Jun 30, 2025	Octavio Espinoza - Officer	Other	Common Stock	224	$91.08	$20K
Jun 30, 2025	Todd C. Davis - Officer	Other	Common Stock	233	$91.08	$21K
Jun 6, 2025	John W. Kozarich - Director	Grant or award	Common Stock	1,209	$0.00	-
Jun 6, 2025	John W. Kozarich - Director	Grant or award	Non-Qualified Stock Option (right to buy)	5,783	$0.00	-
Jun 6, 2025	John L. Lamattina - Director	Grant or award	Common Stock	1,209	$0.00	-
Jun 6, 2025	John L. Lamattina - Director	Grant or award	Non-Qualified Stock Option (right to buy)	5,783	$0.00	-
Jan 17, 2025	John W. Kozarich - Director	Option exercise	Common Stock	2,406	$52.30	$126K
Jan 17, 2025	John W. Kozarich - Director	Option exercise	Non-Qualified Stock Option (right to buy)	2,406	$0.00	-
Dec 23, 2024	Octavio Espinoza - Officer	Open-market sale	Common Stock	2,104	$116.37	$245K
Dec 5, 2024	Octavio Espinoza - Officer	Tax withholding / forfeiture	Common Stock	1,859	$123.51	$230K

Recent LGND Form 8-K filings

Read LGND company news

Sep 24, 2026Item 7.01, 8.01

Read the filing on SEC EDGAR

Sep 22, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Sep 2, 2026Item 9.01

Read the filing on SEC EDGAR

Aug 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Recent LGND Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 10, 2026	MARTINE ZIMMERMANN	Director	1,200	$342K	View on EDGAR
Sep 3, 2026	ANDREW REARDON	Officer	15,000	$4.30M

Congress trades in LGND

All congress trades

Stock trades in LGND disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Gilbert Ray Cisneros, Jr.Democrat, CA-31	Purchase

LGND insider trading FAQ

What is the latest insider trade for LGND?

LIGAND PHARMACEUTICALS INC (LGND) had 7 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for LGND runs to 61 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying LGND stock?

No insider purchases of LGND were filed in the last 90 days.

How many insiders are selling LGND stock?

24 insider sales of LGND were filed in the last 90 days, totaling $16.07M.

Where can I see LGND SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects LGND Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 6, 2026 - Andrew Reardon view on EDGAR
Sep 24, 2026 - Martine Zimmermann view on EDGAR
Sep 14, 2026 - Martine Zimmermann view on EDGAR
Sep 8, 2026 - Andrew Reardon view on EDGAR
Aug 14, 2026 - Octavio Espinoza view on EDGAR
Aug 14, 2026 - Jason Haas view on EDGAR
Aug 4, 2026 - Andrew Reardon view on EDGAR
Jul 6, 2026 - Andrew Reardon view on EDGAR
Jul 6, 2026 - Octavio Espinoza view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where LGND's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow LGND with a 7-day demo

LGND on your watchlist
Every LGND Form 4 filing on record
Up to 3 months of LGND price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

54,979

$16.07M

Option exercise

86,238

Tax withholding / forfeiture

115

Date

Insider

Transaction

Security

Price

Value

Mar 23, 2026

Stephen L. Sabba - Director

Open-market sale

Common Stock

1,000

$207.87^{footnote F2}

$208K

Footnote F2 (price): The price, as represented in Column 4, represents an average price per share of the following transactions on 23 March 2026: 100 shares at $208.055000, 17 shares at $207.980000, and 883 shares at $207.850000.

Mar 11, 2026

Octavio Espinoza - Officer

Option exercise

Employee Stock Option (right to buy)

2,405^{footnote F1}

$0.00

Mar 11, 2026

Octavio Espinoza - Officer

Option exercise

Common Stock

2,405^{footnote F1}

$92.65

$223K

Mar 11, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

3,057^{footnote F1}

$225.00

$688K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

1,142^{footnote F1}

$208.87^{footnote F10}

$239K

Mar 4, 2026

Andrew Reardon - Officer

Option exercise

Employee Stock Option (right to buy)

5,000^{footnote F1}

$0.00

Mar 4, 2026

Andrew Reardon - Officer

Option exercise

Common Stock

5,000^{footnote F1}

$52.27

$261K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

100^{footnote F1}

$197.70^{footnote F2}

$20K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

100^{footnote F1}

$199.01

$20K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

207^{footnote F1}

$199.96^{footnote F3}

$41K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

93^{footnote F1}

$200.62^{footnote F4}

$19K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

300^{footnote F1}

$201.70

$61K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

200^{footnote F1}

$204.17^{footnote F5}

$41K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

460^{footnote F1}

$205.18^{footnote F6}

$94K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

340^{footnote F1}

$206.37^{footnote F7}

$70K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

612^{footnote F1}

$207.01^{footnote F8}

$127K

Mar 4, 2026

Andrew Reardon - Officer

Open-market sale

Common Stock

1,446^{footnote F1}

$208.12^{footnote F9}

$301K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 24, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.5800 to $198.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.8800 to $200.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.5800 to $200.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $203.8600 to $204.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.8400 to $205.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $205.6000 to $206.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $206.6800 to $207.5100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F9 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.6700 to $208.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F10 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $208.6000 to $208.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

698^{footnote F1}

$201.09^{footnote F4}

$140K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

950^{footnote F1}

$201.73^{footnote F5}

$192K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

697^{footnote F1}

$202.79^{footnote F6}

$141K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

668^{footnote F1}

$203.63^{footnote F7}

$136K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

743^{footnote F1}

$204.74^{footnote F8}

$152K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

1,457^{footnote F1}

$205.79^{footnote F9}

$300K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

1,588^{footnote F1}

$206.89^{footnote F10}

$329K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

2,457^{footnote F1}

$207.91^{footnote F11}

$511K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

3,413^{footnote F1}

$208.80^{footnote F12}

$713K

Mar 4, 2026

Octavio Espinoza - Officer

Option exercise

Employee Stock Option (right to buy)

1,607^{footnote F1}

$0.00

Mar 4, 2026

Octavio Espinoza - Officer

Option exercise

Employee Stock Option (right to buy)

466^{footnote F1}

$0.00

Mar 4, 2026

Octavio Espinoza - Officer

Option exercise

Common Stock

1,607^{footnote F1}

$58.49

$94K

Mar 4, 2026

Octavio Espinoza - Officer

Option exercise

Common Stock

466^{footnote F1}

$80.72

$38K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

699^{footnote F1}

$198.71^{footnote F2}

$139K

Mar 4, 2026

Octavio Espinoza - Officer

Open-market sale

Common Stock

53^{footnote F1}

$200.08^{footnote F3}

$11K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.3700 to $199.2500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4400 to $200.0900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.5000 to $201.3400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.4600 to $202.3300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.4000 to $203.0500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $203.4100 to $203.8600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.4600 to $205.3600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F9 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $205.3700 to $206.3600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F10 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $206.4700 to $207.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F11 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.4100 to $208.3500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F12 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $208.3900 to $208.9500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Mar 3, 2026

Stephen L. Sabba - Director

Option exercise

Non- Qualified Stock Option (right to buy)

2,034

$0.00

Mar 3, 2026

Stephen L. Sabba - Director

Option exercise

Common Stock

2,034

$69.51

$141K

Mar 3, 2026

Stephen L. Sabba - Director

Open-market sale

Common Stock

2,034

$201.50

$410K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

41^{footnote F1}

$200.40^{footnote F4}

$8K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

83^{footnote F1}

$201.65^{footnote F5}

$17K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

50^{footnote F1}

$202.54^{footnote F6}

$10K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

42^{footnote F1}

$203.57

$9K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

47^{footnote F1}

$197.14^{footnote F2}

$9K

Mar 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

204^{footnote F1}

$199.69^{footnote F3}

$41K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.0650 to $197.2000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4100 to $200.0550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.1050 to $200.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.2150 to $202.0500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.1500 to $202.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Feb 14, 2026

Andrew Reardon - Officer

Grant or award

Common Stock

6,928

$0.00^{footnote F1}

Feb 14, 2026

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

3,211^{footnote F2}

$183.83

$590K

Feb 14, 2026

Andrew Reardon - Officer

Grant or award

Common Stock

8,810

$0.00^{footnote F1}

Feb 14, 2026

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

4,083^{footnote F2}

$183.83

$751K

Feb 15, 2026

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

593^{footnote F3}

$183.83

$109K

Feb 15, 2026

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

801^{footnote F3}

$183.83

$147K

Feb 15, 2026

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

992^{footnote F3}

$183.83

$182K

Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs").
Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs.
Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Feb 14, 2026

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

4,483^{footnote F2}

$183.83

$824K

Feb 15, 2026

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

1,026^{footnote F3}

$183.83

$189K

Feb 15, 2026

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

1,223^{footnote F3}

$183.83

$225K

Feb 15, 2026

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

1,270^{footnote F3}

$183.83

$233K

Feb 14, 2026

Octavio Espinoza - Officer

Grant or award

Common Stock

7,390

$0.00^{footnote F1}

Feb 14, 2026

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

3,761^{footnote F2}

$183.83

$691K

Feb 14, 2026

Octavio Espinoza - Officer

Grant or award

Common Stock

8,810

$0.00^{footnote F1}

Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs").
Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs.
Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Feb 14, 2026

Todd C. Davis - Officer

Grant or award

Common Stock

20,782

$0.00^{footnote F1}

Feb 14, 2026

Todd C. Davis - Officer

Tax withholding / forfeiture

Common Stock

8,178^{footnote F2}

$183.83

$1.50M

Feb 14, 2026

Todd C. Davis - Officer

Grant or award

Common Stock

39,644

$0.00^{footnote F1}

Feb 14, 2026

Todd C. Davis - Officer

Tax withholding / forfeiture

Common Stock

15,600^{footnote F2}

$183.83

$2.87M

Feb 15, 2026

Todd C. Davis - Officer

Tax withholding / forfeiture

Common Stock

2,039^{footnote F3}

$183.83

$375K

Feb 15, 2026

Todd C. Davis - Officer

Tax withholding / forfeiture

Common Stock

4,255^{footnote F3}

$183.83

$782K

Feb 15, 2026

Todd C. Davis - Officer

Tax withholding / forfeiture

Common Stock

2,805^{footnote F3}

$183.83

$516K

Footnote F1 (price): Represents shares of common stock issued upon the vesting and certification of performance stock units ("PSUs").
Footnote F2 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs.
Footnote F3 (shares): Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Feb 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

39^{footnote F1}

$191.00

$7K

Feb 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

1^{footnote F1}

$192.18

$192

Feb 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

23^{footnote F1}

$195.61

$4K

Feb 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

381^{footnote F1}

$196.36^{footnote F2}

$75K

Feb 2, 2026

John W. Kozarich - Director

Open-market sale

Common Stock

23^{footnote F1}

$197.20

$5K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.0100 to $196.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Dec 12, 2025

Octavio Espinoza - Officer

Open-market sale

Common Stock

1,804

$188.31

$340K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

92^{footnote F1}

$193.86^{footnote F2}

$18K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

179^{footnote F1}

$194.76^{footnote F3}

$35K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

47^{footnote F1}

$195.80^{footnote F4}

$9K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

4^{footnote F1}

$196.35^{footnote F5}

$785

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

92^{footnote F1}

$197.72^{footnote F6}

$18K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

23^{footnote F1}

$199.22^{footnote F7}

$5K

Dec 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

30^{footnote F1}

$200.02^{footnote F8}

$6K

Footnote F1 (shares): The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $193.2800 to $194.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $194.2800 to $195.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $195.2800 to $196.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.2800 to $197.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.2800 to $198.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F7 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.2800 to $199.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F8 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.2800 to $200.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Nov 7, 2025

Nancy Ryan Gray - Director

Option exercise

Non-Qualified Stock Option (right to buy)

3,015

$0.00

Nov 7, 2025

Nancy Ryan Gray - Director

Option exercise

Common Stock

3,556

$66.19

$235K

Nov 7, 2025

Nancy Ryan Gray - Director

Open-market sale

Common Stock

3,556

$205.45

$731K

Nov 7, 2025

Nancy Ryan Gray - Director

Option exercise

Common Stock

3,015

$73.57

$222K

Nov 7, 2025

Nancy Ryan Gray - Director

Open-market sale

Common Stock

3,015

$205.45

$619K

Nov 7, 2025

Nancy Ryan Gray - Director

Option exercise

Non-Qualified Stock Option (right to buy)

3,556

$0.00

Nov 7, 2025

John L. Lamattina - Director

Option exercise

Non-Qualified Stock Option (right to buy)

2,145

$0.00

Nov 7, 2025

John L. Lamattina - Director

Option exercise

Non-Qualified Stock Option (right to buy)

2,034

$0.00

Nov 7, 2025

John L. Lamattina - Director

Option exercise

Common Stock

2,145

$66.13

$142K

Nov 7, 2025

John L. Lamattina - Director

Open-market sale

Common Stock

2,145

$205.45

$441K

Nov 7, 2025

John L. Lamattina - Director

Option exercise

Common Stock

2,034

$69.51

$141K

Nov 7, 2025

John L. Lamattina - Director

Open-market sale

Common Stock

2,034

$205.45

$418K

Nov 3, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

49^{footnote F1}

$190.26^{footnote F3}

$9K

Nov 3, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

207^{footnote F1}

$191.25^{footnote F4}

$40K

Nov 3, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

127^{footnote F1}

$192.38^{footnote F5}

$24K

Nov 3, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

84^{footnote F1}

$189.00^{footnote F2}

$16K

Footnote F1 (shares): The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.7150 to $189.5250. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $190.9400 to $191.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $192.1200 to $192.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Oct 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

24^{footnote F1}

$177.60^{footnote F2}

$4K

Oct 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

196^{footnote F1}

$178.41^{footnote F3}

$35K

Oct 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

155^{footnote F1}

$180.01^{footnote F4}

$28K

Oct 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

92^{footnote F1}

$181.18^{footnote F5}

$17K

Footnote F1 (shares): The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
Footnote F2 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $176.6800 to $177.6450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $177.8750 to $178.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $179.4800 to $180.3100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $180.9350 to $181.4000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the… Full note on SEC EDGAR

Sep 23, 2025

Jason Aryeh - Director

Open-market sale

Common Stock

4,418

$170.41

$753K

Sep 23, 2025

Jason Aryeh - Director

Open-market sale

Common Stock

4,628

$170.96

$791K

Sep 23, 2025

Jason Aryeh - Director

Open-market sale

Common Stock

954

$171.92

$164K

Sep 22, 2025

Martine Zimmermann - Director

Tax withholding / forfeiture

Common Stock

115

$170.77

$20K

Sep 2, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

267

$161.51

$43K

Sep 2, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

115

$162.52

$19K

Sep 2, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

$164.25

$14K

Aug 10, 2025

Andrew Reardon - Officer

Tax withholding / forfeiture

Common Stock

1,325

$150.06

$199K

Aug 1, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

467

$131.88

$62K

Jul 10, 2025

John W. Kozarich - Director

Open-market sale

Common Stock

934

$125.00

$117K

Jun 30, 2025

Andrew Reardon - Officer

Other

Common Stock

233

$91.08

$21K

Jun 30, 2025

Octavio Espinoza - Officer

Other

Common Stock

224

$91.08

$20K

Jun 30, 2025

Todd C. Davis - Officer

Other

Common Stock

233

$91.08

$21K

Jun 6, 2025

John W. Kozarich - Director

Grant or award

Common Stock

1,209

$0.00

Jun 6, 2025

John W. Kozarich - Director

Grant or award

Non-Qualified Stock Option (right to buy)

5,783

$0.00

Jun 6, 2025

John L. Lamattina - Director

Grant or award

Common Stock

1,209

$0.00

Jun 6, 2025

John L. Lamattina - Director

Grant or award

Non-Qualified Stock Option (right to buy)

5,783

$0.00

Jan 17, 2025

John W. Kozarich - Director

Option exercise

Common Stock

2,406

$52.30

$126K

Jan 17, 2025

John W. Kozarich - Director

Option exercise

Non-Qualified Stock Option (right to buy)

2,406

$0.00

Dec 23, 2024

Octavio Espinoza - Officer

Open-market sale

Common Stock

2,104

$116.37

$245K

Dec 5, 2024

Octavio Espinoza - Officer

Tax withholding / forfeiture

Common Stock

1,859

$123.51

$230K

Filed

Filer

Relationship

Market value

Notice

Sep 10, 2026

MARTINE ZIMMERMANN

Director

1,200

$342K

View on EDGAR

Sep 3, 2026

ANDREW REARDON

Officer

15,000

$4.30M

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Gilbert Ray Cisneros, Jr.Democrat, CA-31	Purchase

Member

Type

Traded

Disclosed

Value range

Owner

Days to disclose

Filing

Gilbert Ray Cisneros, Jr.Democrat, CA-31

Purchase